Table 1: Comparative evaluation of different parameters in different types of diabetes including LADA.

ParameterType 1Type 2LADAUndiagnosed

Prevalence (%)6.279.259.6

Gender-wise prevalence
 Males (%)38.762.128054.16
 Females (%)61.337.872045.83

Average age (yrs) 2 1 . 6 4 ± 1 . 9 7 5 5 . 6 9 ± 0 . 4 7 4 0 . 8 ± 1 . 4 8 4 4 . 4 6 ± 1 . 5 6
Range (yrs)6–5933–8223–5525–65

Mean age at onset of diabetes (yrs) 1 2 . 5 5 ± 1 . 3 4 4 8 . 0 1 ± 0 . 5 3 3 . 4 ± 2 . 1 5 3 7 . 6 8 ± 1 . 2 8
Range (yrs)2–3030–7522–4420–45

Prevalence in different age groups (%)MFMFMFMF
 <12 years16.6610.52000000
 12–24 years41.6663.15005000
 25–35 years16.6626.310.80.8152011.536.36
 36–45 years16.66015.0415.04602030.7622.72
 >45 years8.33054.1484.142060 57.6940.90

Family history (% patients)
 Present35.4857.075270.81
 Absent65.4242.934829.17

Basal metabolic index (BMI, % patients)
 Underweight (U)38.61.76125
 Healthy (H)5825.57655
 Overweight (H)3.247.31235
 Obese (O)022.905
 Very obese (VOb)02.2700

Mean BMI19.96 ± 0.62927.95 ± 0.2622 ± 0.5525.68 ± 0.65
BMI range13.75–2516–4515–2616.5–34

Treatment regimen (% patients)
 Insulin92.53.52012
 OHA3.565.51653.5
 Insulin + OHA3.529.56034.5

Drug therapy (% patients)
 1 DT96.41823.628
 2 DT3.62823.828
 3 DT02923.812.5
 4 DT021.528.522
 5 DT0309.4

Mean HbA1c levels (%)9.661 ± 1.108.21 ± 0.2510.45 ± 0.757.89 ± 0.47

Mean cholesterol levels (mg/dL)No data available181.96 ± 5.28222.33 ± 26.87210.90 ± 13.59

Mean C-peptide levels (ng/mL)0.36 ± 0.051.26 ± 0.360.34 ± 0.050.63 ± 0.15

GAD autoantibodies0.76 ± 0.050.7 ± 0.060.95 ± 0.061.01 ± 0.07
(units/mL)AbsentAbsentPresentPresent